SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
19207610
Source:
http://linkedlifedata.com/resource/pubmed/id/19207610
Search
Subject
(
55
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0083701
,
umls-concept:C0194810
,
umls-concept:C0205210
,
umls-concept:C0729866
,
umls-concept:C1457887
pubmed:issue
3
pubmed:dateCreated
2009-3-20
pubmed:abstractText
The management of lower urinary tract symptoms that persist after radical prostatectomy remains to be established. We investigated whether an alpha1-blocker, naftopidil, improves LUTS in patients >or=1 year after radical prostatectomy.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9440237
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic alpha-Antagonists
,
http://linkedlifedata.com/resource/pubmed/chemical/Naphthalenes
,
http://linkedlifedata.com/resource/pubmed/chemical/Piperazines
,
http://linkedlifedata.com/resource/pubmed/chemical/naftopidil
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1442-2042
pubmed:author
pubmed-author:IshizakaKazuhiroK
,
pubmed-author:KawamuraNaokoN
,
pubmed-author:KiharaKazunoriK
,
pubmed-author:MachidaTatsuyaT
,
pubmed-author:NakamuraKeisukeK
,
pubmed-author:TanakaMasakiM
pubmed:issnType
Electronic
pubmed:volume
16
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
299-302
pubmed:meshHeading
pubmed-meshheading:19207610-Adrenergic alpha-Antagonists
,
pubmed-meshheading:19207610-Aged
,
pubmed-meshheading:19207610-Aged, 80 and over
,
pubmed-meshheading:19207610-Dose-Response Relationship, Drug
,
pubmed-meshheading:19207610-Drug Administration Schedule
,
pubmed-meshheading:19207610-Follow-Up Studies
,
pubmed-meshheading:19207610-Humans
,
pubmed-meshheading:19207610-Male
,
pubmed-meshheading:19207610-Naphthalenes
,
pubmed-meshheading:19207610-Patient Satisfaction
,
pubmed-meshheading:19207610-Piperazines
,
pubmed-meshheading:19207610-Postoperative Complications
,
pubmed-meshheading:19207610-Prostatectomy
,
pubmed-meshheading:19207610-Prostatic Neoplasms
,
pubmed-meshheading:19207610-Quality of Life
,
pubmed-meshheading:19207610-Risk Assessment
,
pubmed-meshheading:19207610-Severity of Illness Index
,
pubmed-meshheading:19207610-Time Factors
,
pubmed-meshheading:19207610-Treatment Outcome
,
pubmed-meshheading:19207610-Urination Disorders
,
pubmed-meshheading:19207610-Urodynamics
pubmed:year
2009
pubmed:articleTitle
Clinical efficacy of naftopidil on lower urinary tract symptoms after radical prostatectomy.
pubmed:affiliation
Department of Urology, Kanto Central Hospital, Tokyo, Japan. ishizaka@kanto-ctr-hsp.com
pubmed:publicationType
Journal Article